These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 22143403)

  • 1. Bayesian analysis on meta-analysis of case-control studies accounting for within-study correlation.
    Chen Y; Chu H; Luo S; Nie L; Chen S
    Stat Methods Med Res; 2015 Dec; 24(6):836-55. PubMed ID: 22143403
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Meta-analysis of studies with bivariate binary outcomes: a marginal beta-binomial model approach.
    Chen Y; Hong C; Ning Y; Su X
    Stat Med; 2016 Jan; 35(1):21-40. PubMed ID: 26303591
    [TBL] [Abstract][Full Text] [Related]  

  • 3. mmeta: An R Package for Multivariate Meta-Analysis.
    Luo S; Chen Y; Su X; Chu H
    J Stat Softw; 2014 Jan; 56(11):11. PubMed ID: 24904241
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A meta-analysis of the relationship between NAT2 polymorphism and colorectal cancer susceptibility.
    Liu H; Fu ZX; Wang CY; Qian J; Xing L; Liu YW
    Medicina (Kaunas); 2012; 48(3):117-31. PubMed ID: 22588343
    [TBL] [Abstract][Full Text] [Related]  

  • 5. An Empirical Bayes Method for Multivariate Meta-analysis with an Application in Clinical Trials.
    Chen Y; Luo S; Chu H; Su X; Nie L
    Commun Stat Theory Methods; 2014 Jul; 43(16):3536-3551. PubMed ID: 25089070
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association Between N-acetyltransferase 2 Polymorphism and Bladder Cancer Risk: Results From Studies of the Past Decade and a Meta-Analysis.
    Wu H; Wang X; Zhang L; Mo N; Lv Z
    Clin Genitourin Cancer; 2016 Apr; 14(2):122-9. PubMed ID: 26585839
    [TBL] [Abstract][Full Text] [Related]  

  • 7. N-acetyltransferase 2 status and gastric cancer risk: a meta-analysis.
    Yu J; Deng Y; Chen JP
    Tumour Biol; 2014 Jul; 35(7):6861-5. PubMed ID: 25051916
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Meta-analysis of 20 case-control studies on the N-acetyltransferase 2 acetylation status and colorectal cancer risk.
    Ye Z; Parry JM
    Med Sci Monit; 2002 Aug; 8(8):CR558-65. PubMed ID: 12165742
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pooling controls from different studies.
    Raghunathan TE
    Stat Med; 1991 Sep; 10(9):1417-26. PubMed ID: 1833805
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association between N-Acetyltransferase 2 Polymorphism and Bladder Cancer Risk: a Meta-Analysis in a Single Ethnic Group.
    Xu WJ; Wen LP; Jiang XX; Ye LY; Meng FH; Guan S; Qian YJ; Wei JF
    Clin Lab; 2017 Feb; 63(2):287-293. PubMed ID: 28182356
    [TBL] [Abstract][Full Text] [Related]  

  • 11. NAT2 slow acetylation, GSTM1 null genotype, and risk of bladder cancer: results from the Spanish Bladder Cancer Study and meta-analyses.
    García-Closas M; Malats N; Silverman D; Dosemeci M; Kogevinas M; Hein DW; Tardón A; Serra C; Carrato A; García-Closas R; Lloreta J; Castaño-Vinyals G; Yeager M; Welch R; Chanock S; Chatterjee N; Wacholder S; Samanic C; Torà M; Fernández F; Real FX; Rothman N
    Lancet; 2005 Aug 20-26; 366(9486):649-59. PubMed ID: 16112301
    [TBL] [Abstract][Full Text] [Related]  

  • 12. NAT2 gene polymorphism and sporadic colorectal cancer. Prevalence, tumor stage and prognosis. A preliminary study in 70 patients.
    Osian G; Procopciuc L; Vlad L
    J Gastrointestin Liver Dis; 2006 Dec; 15(4):347-53. PubMed ID: 17205146
    [TBL] [Abstract][Full Text] [Related]  

  • 13. NAT2 polymorphisms combining with smoking associated with breast cancer susceptibility: a meta-analysis.
    Zhang J; Qiu LX; Wang ZH; Wang JL; He SS; Hu XC
    Breast Cancer Res Treat; 2010 Oct; 123(3):877-83. PubMed ID: 20180012
    [TBL] [Abstract][Full Text] [Related]  

  • 14. NAT2 polymorphism and lung cancer risk: a meta-analysis.
    Cui D; Wang Z; Zhao E; Ma J; Lu W
    Lung Cancer; 2011 Aug; 73(2):153-7. PubMed ID: 21292342
    [TBL] [Abstract][Full Text] [Related]  

  • 15. N-Acetyltransferase 2 genetic polymorphisms and risk of colorectal cancer.
    da Silva TD; Felipe AV; de Lima JM; Oshima CT; Forones NM
    World J Gastroenterol; 2011 Feb; 17(6):760-5. PubMed ID: 21390146
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential association for N-acetyltransferase 2 genotype and phenotype with bladder cancer risk in Chinese population.
    Quan L; Chattopadhyay K; Nelson HH; Chan KK; Xiang YB; Zhang W; Wang R; Gao YT; Yuan JM
    Oncotarget; 2016 Jun; 7(26):40012-40024. PubMed ID: 27223070
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of NAT1 and NAT2 genetic polymorphisms on colorectal cancer risk associated with exposure to tobacco smoke and meat consumption.
    Lilla C; Verla-Tebit E; Risch A; Jäger B; Hoffmeister M; Brenner H; Chang-Claude J
    Cancer Epidemiol Biomarkers Prev; 2006 Jan; 15(1):99-107. PubMed ID: 16434594
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association between N-acetyltransferase 2 polymorphisms and pancreatic cancer risk: a meta-analysis.
    Liang JX; Gao W; Liang Y; Zhou XM
    Genet Mol Res; 2015 Dec; 14(4):17219-27. PubMed ID: 26681215
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Possible association of NAT2 polymorphism with laryngeal cancer risk: an evidence-based meta-analysis.
    Ying XJ; Dong P; Shen B; Wang J; Wang S; Wang G
    J Cancer Res Clin Oncol; 2011 Nov; 137(11):1661-7. PubMed ID: 21877196
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.